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ABSTRACT  
MATTHEW ROBERT MASON: Microbiological Analysis of a Humanized Oral Microbiome 
Murine Model  




Aims: Oral bacteria are key players in periodontitis etiology. However, mechanistic 
studies of their pathogenicity are hampered by the lack of animal models that recapitulate the 
human oral microbiota. This study aimed at developing a ‘humanized’ murine model of the oral 
microbiome. Materials and Methods: Full mouth supra and subgingival plaque samples were 
collected from periodontally healthy (H, n=1) and periodontitis (P, n=2) donors. Each donor 
sample was transplanted by oral gavage into five BALB/c germ free mice. Inoculated mice were 
sampled via oral swabs at 1, 7, 28, and 42 days post-transplantation. On day 42, a single silk 
ligature was installed between the first and second maxillary right molars. After 10 days, 
ligatures were removed, animals were sacrificed, maxillas were collected for micro-CT analysis, 
and linear measurements were compared between groups using non-parametric tests. The 
microbial composition of all oral swabs and ligatures was determined using 16S rRNA 
sequencing (MiSeq, Illumina) and analyzed using the ProbeSEQ pipeline. Results: Human 
microbial colonization was observed in the oral cavity of inoculated germ free mice at all time-
points. Samples from H donors harbored 66% of Streptococcus sp., a genus that also 
predominated the oral cavity of H-inoculated mice at day 42, ranging from 19%-71%. 
Streptococcus were also abundant in P-donor samples, comprising 19% of the microbiota and 
dominated the oral cavity of the P-inoculated mice (67-97% of the microbiota). Ligature 
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placement led to an increase in bacterial diversity, with Fusobacterium sp., Veillonella sp. and 
Haemophilus sp. representing up to 12%, 67% and 77% of the sample microbial composition, 
respectively. The number of total OTUs in the healthy group ranged from 64 to 149; whereas, the 
number of total OTUs in the periodontitis group ranged from 16 to 20. In contrast to the original 
donor samples, the healthy group had a significantly increased number of species at 42 days 
(p=0.0477, Wilcoxon). Subsequently, the number of new OTUs detected in the healthy group 
ranged from 18 to 51;, whereas, the number of new OTUs detected in the periodontitis group 
ranged from 3 to 5. The number of new OTUs in the healthy group was also significantly more 
than the diseased group (p=o.0497, Wilcoxon). Conclusions: Human oral microbiota can 
colonize germ-free mice, however further development of this model is needed for a better 
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Chapter 1: Periodontal microbiology and animal models of periodontitis 
 
Section 1.1 Introduction 
 
The human body plays host to trillions of bacteria. Previous reports estimated bacterial 
cells out numbered human cells by a magnitude of ten[1]. However, recent reports suggest the 
number of bacterial cells to be of the same order of magnitude of human cells[2]. Bacteria 
colonize the human host immediately after birth with the body providing several habitats for 
colonization including the oral cavity, nasopharynx, gastrointestinal tract, vagina, and skin. 
These locations all compose various topographical, nutritional, physical, and environmental 
characteristics with the human host considered by many to be a collection of microbial 
ecosystems[3]. Bacteria colonize these ecosystems to form organized, cooperating communities 
within these niches, called biofilms[4]. 
The oral ecosystem is the gateway to the human body. The diverse ecosystem is 
composed of various habitats including the tongue, buccal and labial mucosa, alveolar mucosa, 
attached gingiva, teeth, and saliva. The lining of the oral cavity is composed of lining non-
keratinized alveolar mucosa on the cheeks, lips, and alveolar processes and keratinized 
masticatory mucosa on the dorsum of the tongue, hard palate, and the attached gingiva 
surrounding teeth. The attached gingiva forms a soft tissue cuff around the teeth resulting in a 
gingival sulcus with a specialized cellular attachment at the base of the sulcus occurring via 
hemidesmisomes originating from the junctional epithelial cell[5, 6]. The tooth itself is
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composed of a hard, non-shedding, acellular tooth surface. This unique anatomy around the tooth 
produces a supragingival area above the gingival margin on the non-shedding tooth surface, and 
a subgingival area below the gingival margin with a non-shedding tooth surface adjacent to the 
shedding non-keratinized tissue of the gingival sulcus. Collectively, the numerous 
microenvironments of the oral ecosystem are bathed in saliva and provide unique properties for 
microbial colonization resulting in varying microbial composition based on oral biogeography, 
anatomy, and topography[7, 8].  
The discovery of bacteria was first credited to Antoni van Leeuwenhoek, the father of 
microbiology, who used the scrapings from his teeth to view “living animalcules” in his dental 
plaque under a microscope in 1684. As our technology has evolved, so to has our understanding 
of the bacteria that colonize the oral cavity. The multispecies biofilms that colonize these oral 
habitats are dynamic and complex forming an intricate symbiosis with the host. It has been 
shown that, in certain niches this colonization is a very organized event with a specific temporal 
and spatial sequence (reviewed by Kolenbrander[9]). Although these biofilms are present in 
health, extensive work has shown that perturbations in these oral biofilms have been implicated 
as the primary etiologic agents for the development of dental diseases including caries[10] and 
periodontal disease [11, 12]. The following review will focus on the evolution of our 
understanding of the role bacteria play in periodontitis and animals models used to study this 
disease. 
Section 1.2 Role of bacteria in periodontitis 
 
Periodontitis is an infectious-inflammatory disease leading to loss of tooth-supporting 
tissues, nutritional and speech compromise, loss of self-esteem and a lower quality of life 
affecting 64 million US adults[13], and in its severe form affecting 11% worldwide[14]. It is 
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characterized as an inflammatory disease in which a microbial shift from a healthy subgingival 
biofilm to a dysbiotic biofilm drives host-mediated tissue damage[15, 16]. Our understanding of 
the role bacteria play in the etiology of this disease process has evolved longitudinally with the 
advancement of technologies for bacterial detection and characterization. This progressive 
evolution aligns with changing plaque hypotheses that implicate plaque accumulation, virulence 
potential, and specific pathogens as causative agents of disease initiation and progression.  
Work in the late 19th century and early 20th century emphasized the accumulation and 
overgrowth of plaque as the primary reason for dental infections. This work was mainly 
conducted by G.V. Black and W.D. Miller in the late 1800s with the idea “non-specific plaque 
hypothesis” formalized in 1976[17]. Clinically, this concept matched previous work showing an 
increase in gingival inflammation with a refrain from oral hygiene[18, 19]. The primary concept 
for this hypothesis was that an increase in plaque accumulation was responsible for pathogenicity 
and disregarded the potential for varying degrees of virulence introduced by certain bacteria. As 
a result, the primary means for disease control was the mechanical reduction of plaque via 
routine prophylaxis. 
As culture-based techniques and microscopy advanced, so to did our search for specific 
bacterial species that were potentially responsible for dental diseases. The era of the “specific 
plaque hypothesis” postulated that specific species were responsible for disease and that anti-
infective therapy against those species could prevent disease[17, 20]. For periodontal disease, the 
ability to culture anaerobic bacteria, the suspected cohort responsible for subgingival 
inflammation, lead to an influx of new species associated with periodontal disease and suspected 
to be “periopathogens” [11, 21, 22]. The primary concept for this hypothesis was the initiation of 
disease could be associated with certain bacterial species and the virulence inherent to these 
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species. Although the mechanical removal of plaque remained a primary treatment choice, the 
specific plaque hypothesis introduced the concept of adjunctive therapies such as antibiotics in 
the management of disease. 
A primary issue noted with the “specific plaque hypothesis” was that many of the species 
implicated as “periopathogens” were also indigenous community members and often detected in 
healthy sites[23]. This concept brought a shift back to a modified “non-specific plaque 
hypothesis” in which the accumulation of plaque coupled with the virulence of certain species 
were thought to be responsible for disease. This theory also matched emerging longitudinal 
evidence of disease progression from a patient population with limited oral hygiene[24]. In this 
cohort, the disease progression of individuals with heavy plaque accumulation ranged from 
minimal to rapid progression further implicating the quantity and quality of plaque in disease 
progression. 
The limitations of these previous hypotheses, coupled with the advancement of culture-
independent identification techniques, led to the introduction of the “ecological plaque 
hypothesis”[25]. This hypothesis theorized that disease was due to an imbalance of the microbial 
ecology resulting in microbial composition changes that favored disease. The principles of this 
hypothesis were borrowed from the revised “non-specific plaque hypothesis”[23], and 
additionally expanded to include the role ecological factors such as nutrient availability, pH, 
oxygen potential, etc. potentially played in modifying microbial composition[25, 26]. The 
merging of the concepts of the specific and non-specific hypothesis into this ecological model 
were observed clinically with the identification of microbial complexes associated with 
disease[27].  
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Recently, a new hypothesis, termed “keystone-pathogen hypothesis”, has emerged for 
disease initiation and progression[28]. The concepts for this hypothesis are rooted in the 
evidence that some species display a disproportional effect on the environment relative to their 
overall community abundance[29]. The strongest evidence for this hypothesis is supported by a 
collection of work involving Porphyromonas gingivalis, an established oral pathobiont that is 
benign within an indigenous community, but becomes pathogenic when host-microbe 
homeostasis breaks down[30]. Emerging evidence for P. gingivalis indicate low-level detection 
of this species can lead to alterations in community microbial profiles and total inflammation 
facilitating the survival of all species and ultimately leading to an increase in its own survival 
and abundance[31, 32]. In addition to the role of P. gingivalis in modulating microbial 
community abundance, substantial evidence also exists of its role in manipulating the host 
immune response[33]. Lastly, suspected oral keystone pathogens are observed in higher 
abundance in advanced levels of disease[27], however due to the increase in total microbial load 
these pathogens may actually be present in less relative abundance in advanced disease 
states[16]. 
Collectively, our knowledge of periodontal microbiology has seen a drastic shift as 
scientific technology has evolved. We started with a simplistic view based on the quantity of 
plaque being responsible for disease, transitioned to a search for the periodontal pathogen 
responsible for disease, and have emerged into an era where we are now concerned not only with 
the quantity (“who is present”), but also the quality (“who has virulence potential”), and behavior 
(“what functions are they doing”) of the members of the periodontal microbiome. 
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Section 1.3 Animal models of periodontitis 
 
With our evolving view of the periodontal microbiome, the methods we have used to 
study periodontitis in controlled animal models have also progressed. A variety of species have 
been used to study the pathogenesis of periodontitis and therapeutic outcome of treatment with 
the most common species ranging from non-human primates, miniature pigs, canines, and 
rodents. In regards to periodontal pathogenesis, disease can occur naturally over time or be 
initiated experimentally in a variety of techniques for a given animal species. A brief review of 
common species used to study the pathogenesis of periodontitis will be discussed. 
 Non-human primate species are the closest evolutionary lineage to humans. A variety of 
non-human primate species have been used in the research of periodontal disease. These species 
have anatomical similarities to humans and have naturally occurring disease[34]. As in many 
other models of periodontal disease due to the cost of extended housing, plaque retentive 
mechanisms such as orthodontic elastics or ligatures can be placed interproximally to accelerate 
disease initiation and progression[35, 36]. The subsequent addition of human disease-associated 
pathogens via gavage was later used as an additive for pathogenesis[37]. Although an ideal 
model for periodontal pathogenesis, the high expense and increased animal regulations with the 
use of non-human primates ultimately has limited their use for research investigation. 
 Like non-human primates, miniature pigs have a similar anatomy and physiology to 
humans and have been extensively used in biomedical research making them a suitable choice 
for periodontal pathogenesis research[38, 39]. These animals develop gingivitis and progress to 
periodontitis over an extended period of time that can be accelerated with plaque-retentive 
additives and inoculation with human pathogens[39]. However, due to the high expense and 
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husbandry requirements for miniature pigs there are limited data using this model for 
periodontitis progression. 
 Canine models have been used extensively in various models of periodontal surgical 
therapy, wound healing, periodontal regeneration and dental implantology[40-45]. Periodontitis 
occurs at a high rate naturally in canines with a similar course of disease progression to 
humans[46]. Canine models display naturally occurring gingivitis and periodontitis with 
subgingival plaque showing similarities to humans[47]. The additional use of plaque-retentive 
ligatures is also common in the canine model to accelerate disease[48]. The extensive animal 
care regulations for canine research make canine models less attractive for periodontal 
pathogenesis research, despite many similarities with human pathogenesis. 
 Rodent models provide ethical and cost effective alternatives to studying human disease, 
particularly for microbiologic, immunologic, and mechanistic studies. Rats are a common 
species for periodontitis models as they share some similarities with human anatomy and are 
highly susceptible to periodontal disease[49, 50]. However, there is a strong preference for 
periodontal disease depending on the diet of the animal[51]. The use of plaque-retentive ligatures 
is a common practice in rats to accelerate disease and the availability of gnotobiotic rats have 
helped show the primary etiologic role of bacteria in inducing periodontitis[52]. Mouse models 
have been primarily employed to study periodontal disease mechanisms and outcomes of 
therapeutic targets[53] and are commonly employed to measure alveolar bone loss in response to 
bacterial challenge[54]. The construction of specific pathogen-free mice via the use of preloaded 
antibiotics has been useful to assess the virulence of potential periodontal pathogens[55, 56]. 
Additionally, chemical inoculation has been used to generate mouse models of chronic 
inflammation mimicking the disease inflammatory process[57]. Until recently, the ligature model 
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for periodontitis was reserved for larger animals, primarily due to ease of use and feasibility. The 
introduction and optimization of the murine ligature-induced periodontitis model conveniently 
allows the initiation of disease in a predictable manner with rapid and localized periodontal 
destruction[58, 59].  
With the molecular toolkit available to produce specific genetic alterations for 
mechanistic study, the developing techniques to study periodontal pathogenesis using a ligature-
induced periodontitis model, and the ethical, cost-effective, and reproducible means to study 
disease progression, the mouse model will continue to be attractive for future investigation. 
Seminal findings have demonstrated that low-abundance species, such as Porphyromonas 
gingivalis, can have a community-wide impact, disrupting the host-microbial symbiosis to cause 
periodontitis in germ free and conventional mice[31]. Whilst this work has advanced our 
understanding of the pathogenesis of periodontitis, the animal models employed to date do not 
possess or mimic the human oral microbiome and fail to reflect the complex human microbial 
communities that drive the disruptive and ultimately destructive immune-inflammatory 
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Chapter 2: Microbiological analysis of a humanized murine microbiome model pilot study 
 
Section 2.1 Introduction 
 
Periodontitis, an infection leading to loss of the supporting tissues of the dentition, is one 
of the most prevalent and significant oral diseases affecting 64 million US adults[1]. Bacteria are 
the established primary etiologic agents for periodontitis and begin to inhabit numerous sites on 
and within the human host immediately following birth, collectively forming the ‘human 
superorganism’ [2, 3]. Periodontitis is characterized as a polymicrobial inflammatory disease 
dependent on a microbial shift from a health-associated supragingival biofilm to a disease-
associated subgingival biofilm [4, 5]. Mechanistic studies on the role of oral biofilms in 
periodontitis have been hampered because existing animal models of periodontal diseases 
present an oral microbiota distinct from humans. A knowledge gap exists regarding the microbial 
composition and function of the murine microbiome compared to the human microbiome 
through which the etio-pathology of periodontal disease is examined. This gap is due, in large 
part, to a lack of translational animal models of periodontitis with a “humanized” periodontal 
microbiota. 
Despite taxonomic similarities, many of the species of bacteria found in mice are not 
present in humans and vice versa [6]. This limits our ability to extrapolate data from Specific 
Pathogen Free (SPF) mice to humans. Introduction of human pathogenic bacteria by oral gavage 
into SPF mice and the subsequent impact on the periodontium has been extensively studied
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[7-10]. However, this involves the inoculation of large numbers of periodontal pathogens into the 
oral cavity of SPF mice, resulting in a microbial challenge that does not fully mimic the human 
oral microbiota and its complexity. Further, the endogenous bacteria in SPF compete with the 
colonization of human bacterial species, often requiring a regimen of antibiotics to ‘open’ the 
habitat to the colonization of the bacteria being inoculated. To circumvent this endogenous 
competition, the use of germ free mice have been explored for microbial transplantation. 
Successful transplantation of fecal microbiota from colorectal cancer patients and healthy 
individuals into germ free mice have demonstrated the feasibility for this method with the 
generation of structurally distinct microbial communities [11].  
Thus, the sterile environment of germ free mouse is an attractive model for humanization 
with host microbes. We hypothesized that the oral microbiota that distinguishes periodontal 
healthy from periodontitis subjects would also be reproduced in GF mice. The aim of this pilot 
study was to test our central hypothesis that the human oral microbiota can be successfully 
reproduced in the oral cavity of GF mice to generate an ‘oral microbiota humanized murine 
model’. 
Section 2.2 Materials and methods 
 
Clinical study design: Study subjects were recruited via self-identification to flyers, digital 
marketing, and word of mouth to the GO Health Clinic at the UNC School of Dentistry (IRB#16-
1874). A total of 20 potential participants were screened, to identify three eligible participants 
who committed to return for further sampling. A calibrated dental examiner performed a 
screening examination of the subject’s pocket depth (PD), clinical attachment level (CAL) and 
bleeding on probing (BOP) in 6 sites per tooth for every tooth present. Two patients were 
identified with periodontitis and one patient was identified as periodontally healthy. 
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Study participants were selected as follows:  
General Inclusion Criteria: 
 Have at least 20 teeth; 
 Age 21-80, inclusive;  
 Good general health as evidenced by the medical history; 
 Ability to read, understand, and sign a consent form. 
Inclusion Criteria for Periodontitis Subjects:  
 Having at least 6 teeth with pocket depth (PD) >4 mm and clinical attachment level 
(CAL) >2 mm; 
Inclusion Criteria for Periodontally Healthy Subjects:  
 No sites with pocket depth (PD) >3 mm and clinical attachment level (CAL) >2 mm; 
 Less than 20% of sites with BOP. 
Exclusion Criteria:  
 Periodontal or antibiotic therapy in the previous 6 months; 
 Any systemic condition that might influence periodontal disease or treatment (e.g. 
diabetes, HIV, cancer); 
 Any systemic condition that requires antibiotic coverage for periodontal procedures 
(e.g. heart conditions, joint replacement); 
 Chronic use (i.e., two weeks or more) of any medication known to affect periodontal 
status (e.g., phenytoin, calcium antagonists, cyclosporine, non-steroidal anti-
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inflammatories and anticoagulants) within 3 months of the visit 1. (Daily use of 81mg 
Aspirin was allowed); 
 Use of tobacco products within the previous 12 months; 
 Use of anticoagulant therapy not easily reversed such as oral thrombin inhibitor;  
 Pregnant or lactating females (because hormonal changes associated with pregnancy 
are known to affect the periodontal microbiome); 
 Current participation in another randomized clinical trial. 
Three subjects were requested to return to clinic for oral plaque sampling. The subjects 
were asked to refrain from oral hygiene for 24 hours prior to their scheduled visit. Supragingival 
and subgingival samples were collected from every site of all teeth from each patient for 
inoculum preparation. After collection, dental plaque samples were placed in 1ml of Pre-reduced 
Anaerobic Sterilized solution (PRAS) under the influx of nitrogen gas to maintain viability of the 
oral microorganisms. 
Laboratory methods: Human oral microbiome transplantation: The collected samples were 
transferred to the laboratory and centrifuged (1000 rpm, 5 min) to pellet the microorganisms. The 
supernatant was removed and the microbial cells were resuspended in 200 µl of PRAS. One 
aliquot of 50 µl was set aside for sequencing (original microbiota control) and the remaining 150 
µl of microbial suspension was mixed with 150 µl of 4% carboxymethylcellulose (CMC) in 
PRAS to prepare the final inoculum. The inoculum was transported to the (National Gnotobiotic 
Rodent Resource Center, University of North Carolina CB7115, Chapel Hill) for transplantation. 
Germ-free mice were removed from the isolator and moved to red-line cages. A final inoculum 
of 50μl oral microbial suspension with 2% CMC was transplanted by oral cavity gavage into five 
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germ-free mice. Mice were housed in red-line cages with sterile water and chow, and were not 
returned to the isolator for the remainder of the study. 
In total, 15 germ-free BALB/c mice were transfected; 5 mice transfected with biofilm 
from the periodontally healthy volunteer and 5 mice with samples from each periodontitis patient 
All animals were 6-8-week-old, females at the time of transplantation. Oral microbial samples 
were collected via sterile swab for 10 seconds. Samples were collected at baseline, day 1, 7, 28, 
and 42 after transplantation for assay. At day 42, a silk ligature was placed interproximally 
between the maxillary first and second molar. The ligature was left for 10 days and was collected 
for assay. DNA was isolated from samples using an Epicentre Masterpure DNA kit (Madison, 
WI) and microbial DNA was enriched using a NEBNext Microbiome DNA Enrichment kit 
(Ipswich, MA) according to the manufacturer’s instructions. Subsequently, microbial DNA was 
linearly amplified using the Illustra GenomiPhi V2 (Marlborough, MA) multiple displacement 
amplification kit according to manufacturer’s instructions. Library generation was done using an 
Illumina TruSeq DNA sample preparation kit according to the manufacturer’s instructions. The 
microbial composition of the source inoculum and the human microbiota that can successfully 
colonize in the oral cavity of GF mice were characterized by next-generation (Illumina) 
sequencing at the UNC Microbiome Core Facility (University of North Carolina, Isaac Taylor 
Hall, Chapel Hill, NC). Sequences were annotated and characterized against the Human Oral 
Microbiome Database[12] using QIIME[13] and the ProbeSEQ pipeline[14]. Statistical analyses 
were carried out using non-parametric tests between groups (SAS, Cary, NC). 
Section 2.3 Results 
 
In total, 38 samples passed adequate quality control to be considered for analysis (Table 
2.1). These 38 samples had 5,878,361 sequencing reads with 1,460,544 not matching to a probe 
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ID (28.34%). Unfortunately, the low yield at multiple time-points restricted robust quantitative 
longitudinal analysis of these data.  
As an overview, the relative microbial abundance of each analyzed sample is shown in 
Figure 2.1. HOMD microbes were detected in all samples at all time points. The lack of an 
adequate baseline donor output and pre-transplantation contamination of these animals excluded 
the first periodontitis samples from further analysis. 
The relative microbial abundance of the second periodontitis and healthy patients at 
baseline and day 42 are shown in Figure 2.2. Collected ligatures that passed sequencing controls 
for the periodontitis group are also shown. At baseline, the periodontitis and healthy samples 
reflect expected profiles respectively. The periodontitis sample has an increased diversity with 
233 Operational Taxonomic Units (OTUs) detected, while the healthy donor sample contains 
160 OTUs. The healthy donor sample harbored 66% Streptococcus sp., with this genus 
predominating at the 42 day mark with relative abundance ranging from 19-71%. The 
periodontitis donor sample contained 19% Streptococcus sp. and dominated the oral cavity at 42 
days with abundance ranging from 67-97% of the microbial composition.  Ligature samples had 
an increased diversity to their 42 day complement with Fusobacterium sp., Veillonella sp., and 




Table 2.1 Samples passing sequencing and characterization quality-control parameters. 
1Disease 2Disease Healthy
Pre-transplant 2 * 3
Day 1 3 1 0
Day 7 0 2 2
Day 14 4 * *
Day 28 2 1 2
Day 42 3 4 3








Figure 2.1 Relative abundance of OTUs in animal oral microbiomes and ligatures from all samples passing quality-control in 






Figure 2.2 OTU relative abundance of select animal oral microbiome samples at day 42 and ligatures for healthy and periodontitis 






The total number of OTUs and number of new OTUs not detected in the baseline donor 
sample at 42 days in the healthy and periodontitis groups are shown in Figure 2.3. The number of 
total OTUs in the healthy group ranged from 64 to 149; whereas, the number of total OTUs in 
the periodontitis group ranged from 16 to 20 (Figure 2.3A). In contrast to the original donor 
samples, the healthy group had a significantly increased number of species at 42 days (p=0.0477, 
Wilcoxon). Subsequently, the number of new OTUs detected in the healthy group ranged from 
18 to 51;, whereas, the number of new OTUs detected in the periodontitis group ranged from 3 to 
5 (Figure 2.3B). The number of new OTUs in the healthy group was also significantly more than 
the diseased group (p=o.0497, Wilcoxon). 
The number and proportion of shared OTUs between day 42 and the original donor 
sample for each group is shown in Figure 2.4.The number of shared OTUs in the healthy group 
ranged from 46 to 51; whereas, the number of total OTUs in the periodontitis group ranged from 
11 to 17 (Figure 2.4A). The number of shared OTUs was not significantly different between 
groups (p=0.0518, Wilcoxon). Additionally, given the varying number of species at baseline, the 
proportion of shared OTUs at day 42 with the donor sample was examined (Figure 2.4B). The 
proportion of shared OTUs in the healthy group ranged from 19% to 42%; whereas, the 
proportion of shared OTUs in the periodontitis group ranged from 4% to 7%. The proportion of 
shared OTUs was not significantly different between groups (p=0.0518, Wilcoxon). 
Lastly, the OTUs present at day 42 in all healthy and periodontitis samples respectively 
were identified (Table 2.2). There were 34 OTUs detected in the three, day 42 healthy samples. 






Figure 2.3 Total and new OTU count by group. (A) Total number of OTUs detected in healthy and periodontitis groups at 42 
days. Oral microbiome samples from mice transplanted with healthy microbiome donors have significantly more detectable 
OTUs (p=0.0477, Wilcoxon). (B) Total number of new OTUs not detected in baseline donor microbial samples present in animal 
oral microbiome samples at 42 days. Oral microbiome samples from mice transplanted with healthy microbiome donors have 









Figure 2.4 Shared and proportion of shared OTUs by group. (A) Number of shared OTUs detected between baseline and 42 days 
in healthy and periodontitis groups. No significant differences in the number of shared species between groups were observed 
(p=0.0518, Wilcoxon). (B) Proportion of shared OTUs detected at day 42 with baseline donor sample between healthy and 








Table 2.2 OTUs detected in all samples at 42 days (4 
periodontitis animals, 3 healthy animals). OTUs with an 
* indicate OTUs not detected at baseline (7 in healthy 
group) 



































34 OTUs 8 OTUs
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detected in the four day 42 periodontitis samples all of which were present in the periodontitis 
donor sample.  
Section 2.4 Discussion 
 
To our knowledge, the work completed in this pilot study is the first evidence of using 
human oral plaque samples directly transferred to germ-free animals. We hypothesized that the 
oral microbiota from periodontally healthy and periodontitis subjects would also be reproduced 
in germ-free mice and aimed to generate an ‘oral microbiota humanized murine model’. The 
preliminary results from this work suggest the generation of a predictable model might not be 
obtained with the current methodology, however the results do suggest transplanted human 
microbes are capable of colonizing the murine oral cavity.  
Using 16s deep sequencing and ProbeSEQ (citation) to characterize the microbial profiles 
of our samples, HOMD OTUs were detected in all analyzed samples at all time-points. Healthy 
and periodontitis donor samples resembled current knowledge of microbial composition and 
diversity [15-17]. The periodontitis donor sample harbored a community with increased 
microbial diversity compared to the healthy donor sample. Interestingly, this increased 
complexity at baseline was not conferred to the animal and potentially interfered with the 
traditional succession of microbial colonization[18]. The result was a final community 
dominated by Streptococcus sp. and limited microbial diversity. In contrast, the healthy 
transplanted animals had significantly more OTUs present in their community at day 42. The 
lack of initial microbial competition in these animals may have contributed to the community 
development seen throughout the duration of this study. Additionally, the healthy transplanted 
animals exhibited a strong trend to share increased numbers of OTUs with their baseline. 
Although this increased similarity was not statistically significant, the minimal sample size likely 
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contributed to this finding. Increasing the numbers of animals transplanted would potentially 
gain the necessary power to detect this suspected difference between groups.  
Four ligature samples that passed quality control all showed an increase in sample 
complexity compared to their periodontitis counterparts. The marked inclusion of Fusobacterium 
sp., a known intermediary species in microbial succession[19], suggests complex communities 
are capable of forming from transplantation. The anatomical location of the ligature may be a 
more ideal location to capture the true “periodontal microbiome” adjacent to the teeth rather than 
the oral swab technique employed in this study. 
Numerous limitations exist in this work, indicative of the nature of a pilot study. First, the 
animals were moved from the germ-free isolator prior to sequencing and were not returned to the 
isolator after transplantation due to the cost of housing and complexity of running the study in 
this format. As was seen in pre-transplanted samples, this likely resulted in some contamination 
prior to transplantation and led to the minimization of interpreting our first periodontitis 
transplant cohort. Additionally, the influx of new OTUs not found in our donor samples were 
detected at all time-points after transplantation. Interestingly, the animals transplanted with a 
healthy microbial donor had significantly more new OTUs in their samples. This observation 
may be attributed to the robust colonization that occurred in this group due to the potentially 
reduced colonization competition as proposed earlier. Second, the techniques employed in 
sample collection and subsequent sample preparation for sequencing resulted in many samples 
failing to meet quality control metrics. This was likely due to the minimal biomass available 
using the swab technique for oral microbial collection. Additionally, ligatures were left for 10 
days and were occasionally missing upon retrieval. Recently, another group has discussed these 
issues and implemented a standardized protocol to alleviate some of these concerns[20]. Lastly, 
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our group recognizes a single transplantation step is likely an unrealistic approach to generate a 
robust model. A protocol with multiple transfections to mimic the microbial colonization 
patterns may lead to a profile closer resembling our current understanding of health and disease 
characteristics in the periodontal microbiome. However, the use of a human donor does 
complicate the implementation of multiple transfections as this would bring in issues with patient 
compliance and patient microbial recolonization following the original sampling. 
In conclusion, the work outlined in this pilot study does provide evidence that microbes 
from human plaque samples transplanted into germ-free mice can colonize and survive for 
extended periods of time following transplantation. However, additional work is needed to create 
a reproducible ‘oral microbiota humanized murine model’ that is attractive for future studies 
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Chapter 3: Future directions 
 
The continued development of our “humanized” murine model is a powerful tool for 
potential mechanistic studies on the role of the oral microbiome in the development of 
periodontitis. In future work with optimizing this model, the use of an in-vitro developed multi-
species biofilm will be considered for ease of use and reproducibility. Additionally, transfection 
at continued intervals may be indicted. Periodontal pathogens often are secondary colonizers of 
the biofilm. Therefore, multiple transfections to seed the primary colonizers may be necessary 
for optimal colonization of the periodontal pathogens. Subsequently, the use of isolators may be 
considered to avoid contamination of microbial sampling. 
The nature of the host immune system response to this polymicrobial community, the role 
it plays in development of chronic lesions, and the maintenance of periodontal health are future 
areas of investigation with this model. Specifically, the development of this model will provide 
insight on the development of the oral microbiome and the role host immunity plays in this 
synchronized maturation. Increasing our understanding of both the role of the oral microbiome 
and how our bodies respond to this challenge is imperative for the development of future targets 
and therapies to manipulate these systems, predictively treat disease, and promote health. Our 
preliminary work to date has initiated a new avenue to study the oral microbiome in an animal 
model; however, how the “humanized” oral microbiome influences the development of the 
innate immune response warrants additional examination. 
